These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 17216598)

  • 21. Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones.
    Gosselin RD; Varela C; Banisadr G; Mechighel P; Rostene W; Kitabgi P; Melik-Parsadaniantz S
    J Neurochem; 2005 Nov; 95(4):1023-34. PubMed ID: 16150057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
    Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
    Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression.
    Fernández-Martínez AB; Collado B; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Mol Cell Endocrinol; 2007 May; 270(1-2):8-16. PubMed ID: 17434257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
    Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
    Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
    Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
    Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of differentially expressed genes in LNCaP prostate cancer progression model.
    Xie BX; Zhang H; Wang J; Pang B; Wu RQ; Qian XL; Yu L; Li SH; Shi QG; Huang CF; Zhou JG
    J Androl; 2011; 32(2):170-82. PubMed ID: 20864652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
    Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
    Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
    Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
    Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
    Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis.
    Narita S; Tsuchiya N; Saito M; Inoue T; Kumazawa T; Yuasa T; Nakamura A; Habuchi T
    Prostate; 2008 Feb; 68(3):321-35. PubMed ID: 18175332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
    Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
    Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and implication of cyclooxygenase-2 mRNA in prostate cancer].
    Yang MS; Xia SJ; Liu HT; Sun XW; Han BM; Wu JT; Lu J; Ling GM; Tang XD
    Zhonghua Nan Ke Xue; 2006 Feb; 12(2):159-61. PubMed ID: 16519157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of the leptin and leptin receptor expressions in prostate tissues.
    Hoon Kim J; Lee SY; Myung SC; Kim YS; Kim TH; Kim MK
    Asian J Androl; 2008 Nov; 10(6):923-8. PubMed ID: 18958356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.
    Zha S; Gage WR; Sauvageot J; Saria EA; Putzi MJ; Ewing CM; Faith DA; Nelson WG; De Marzo AM; Isaacs WB
    Cancer Res; 2001 Dec; 61(24):8617-23. PubMed ID: 11751373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CaT1 expression correlates with tumor grade in prostate cancer.
    Peng JB; Zhuang L; Berger UV; Adam RM; Williams BJ; Brown EM; Hediger MA; Freeman MR
    Biochem Biophys Res Commun; 2001 Apr; 282(3):729-34. PubMed ID: 11401523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.
    König JE; Senge T; Allhoff EP; König W
    Prostate; 2004 Feb; 58(2):121-9. PubMed ID: 14716737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells.
    Ni J; Pang ST; Yeh S
    Prostate; 2007 Apr; 67(5):463-71. PubMed ID: 17252538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of nucleostemin in prostate cancer tissues and its clinical significance].
    Liu RL; Xu Y; Zhang ZH; Wang M; Sun JT; Qi SY; Zhang Y; Li SZ
    Zhonghua Nan Ke Xue; 2008 May; 14(5):418-22. PubMed ID: 18572860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.